Fosun: Global Conglomerate Creating Value Through Deleveraging

April 9, 2025 in Asia, Asian Investing Summit 2025, Asian Investing Summit 2025 Featured, Audio, Diary, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts

Roshan Padamadan of Luminance Capital presented his investment thesis on Fosun International (HK: 0656 / OTC: FOSUY) at Asian Investing Summit 2025.

Thesis summary:

Fosun International is a sprawling Chinese conglomerate with a globally diversified asset base across healthcare, insurance, consumer products, tourism, and financial services. Following a period of aggressive expansion, Fosun has recently pivoted toward debt reduction — a slow but steady process that is unlocking disproportionate equity value. With over 50% of revenues now generated outside China and holdings in well-known names such as Fidelidade (Portugal), Club Med (France), Cirque du Soleil (Canada), and Gland Pharma (India), Fosun has evolved from a domestic industrial group into a diversified international operator with a unique east-west footprint.

The company recently traded at HKD 4.3 per share, giving it a market cap of HKD 35.2 billion (USD 4.6 billion). Despite having a broad portfolio of operating businesses, the shares were priced at just 0.27x book and 0.18x sales as of early April 2025. While its debt/equity ratio remains high at 1.9x, Fosun has made visible progress on deleveraging, including asset sales of over HKD 30 billion in 2024 alone. Credit markets have responded favorably, with its CDS tightening from 350 bps to near 300 bps over the last two years, and all major rating agencies now maintaining a stable outlook.

Operationally, Fosun remains resilient, with profitability spread across four segments — Health, Happiness, Wealth, and Intelligent Manufacturing — all of which reported profits in 2024. The company is exposed to varying degrees of competition and cyclical risk, particularly in tourism and financial services, but maintains strong geographic diversification, with nearly half of revenues now generated outside China. Despite these assets, market skepticism persists, in part due to the company’s complex structure, its prior ties to China’s property sector, and a modest dividend and buyback program.

Nonetheless, Fosun presents a compelling deep value opportunity for patient investors. With a high-quality global portfolio, tangible progress on debt repayment, and a share price disconnected from intrinsic value, the business offers significant upside potential. As deleveraging continues and market confidence improves, even a partial re-rating to 0.5x book or 0.5x sales could yield material returns. In a market eager for transparency and capital discipline, Fosun’s slow but determined pivot may be precisely the kind of underappreciated transformation that long-term investors should not overlook.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Roshan Padamadan is Chairman at Luminance Capital. He is a global investor and splits his time between New York, Singapore and India. Previously, he served as COO, Risk and Compliance officer at Sixteenth Street Capital, based in Singapore. His erstwhile Luminance Global Fund had a global unconstrained investment strategy, looking at special situations and deep value. Prior to launching Luminance in 2013, Roshan also spent more than seven years with the HSBC Group, including more than three years with HSBC Asset Management, as a Product Specialist. He worked for the highly commended Offshore Indian Equity team which ran US$5+ billion from Singapore, including a US$100+ million award-winning India hedge fund. Roshan has earned an MBA in Management from Indian Institute of Management, Ahmedabad. He holds the CFA and CAIA charters and speaks over five languages.

Narayana: Low-Cost Hospital Operator With Improved ROI Focus

April 9, 2025 in Asia, Asian Investing Summit 2025, Asian Investing Summit 2025 Featured, Audio, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts

Vinod Moras of Kiara Advisors presented his investment thesis on Narayana Hrudayalaya Ltd. (India: NARH) at Asian Investing Summit 2025.

Thesis summary:

Narayana Hrudayalaya is a leading Indian hospital chain founded by the renowned cardiac surgeon Dr. Devi Shetty, with a mission to deliver high-quality healthcare at affordable prices. Since going public in 2016, the company has evolved from a doctor-led institution into a professionally managed, ROI-focused healthcare platform under the leadership of Viren Shetty. With a network of 19 hospitals across India and operations in the Cayman Islands, Narayana has executed a successful transformation by optimizing its asset base, improving clinical efficiency, and expanding EBITDA margins from ~10% to over 22% in just five years.

The company recently traded at ₹1,683 per share, giving it a market capitalization of approximately ₹344 billion ($4 billion), which represents a notable ~27% discount to Indian hospital peers on an EV/EBITDA basis despite stronger operational metrics. Since 2019, Narayana’s revenue has grown 74%, EBITDA has tripled, net income has surged over 500%, and return on equity has expanded fivefold to 31%. This performance has been driven by better occupancy rates, rising average revenue per occupied bed (ARPOB), and increasing insurance penetration. With structural tailwinds in India’s underpenetrated healthcare system and rising middle-class demand, the company is well-positioned for continued profitable growth.

Looking ahead, Narayana is entering an expansion phase with plans to add over 2,000 beds by FY2030, focused on core geographies such as Bangalore and Kolkata. This capital expenditure, totaling INR 29 billion, is expected to be funded entirely through internal accruals. Optionality exists through its successful Cayman Islands operation — which boasts 41% EBITDA margins and a ROCE above 50% — as well as pilot initiatives in integrated health insurance and monetization of its proprietary hospital management software (Athma and Medha). These efforts not only open up new profit pools but also demonstrate the scalability of Narayana’s low-cost, high-quality care model in international and tech-driven settings.

Risks remain, particularly from regulatory pricing caps, wage inflation, and the capital-intensive nature of the hospital business. Moreover, about 30% of EBITDA is derived from a single overseas hospital in the Cayman Islands, introducing some concentration risk. However, with a solid balance sheet, strong management, and multiple growth levers, Narayana offers an attractive blend of proven execution and long-term optionality. As healthcare in India transitions toward organized, insurance-led delivery, Narayana is well-positioned to emerge as a blue-chip compounder in the making.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Vinod Moras is a seasoned value investor with over a decade of experience in Asian equities. He is currently an Investment Manager at Highwest Global Management, overseeing the firm’s India portfolio within its Asia-focused, long-only strategy. Previously, he was Head of Investments at Sixteenth Street Capital, leading research and portfolio strategy for South and Southeast Asia. Vinod also held investment roles at KIARA Advisors and APS Asset Management. Vinod brings operational experience to investing, having worked in the automotive and oil & gas industries before transitioning to finance. He has been a member of the Value Investors Club (VIC) and holds an undergraduate degree in engineering and master’s degree in finance from NYU Polytechnic Institute.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

Suryoday: Financially Secure, Deeply Undervalued Small Finance Bank

April 9, 2025 in Asia, Asian Investing Summit 2025, Audio, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts

Amey Kulkarni of Candor Investing presented his investment thesis on Suryoday Small Finance Bank (India: SURYODAY) at Asian Investing Summit 2025.

Thesis summary:

Suryoday Small Finance Bank is a niche private-sector lender with a significant presence in microfinance and bottom-of-the-pyramid banking. Over the last few years, the bank has been steadily transitioning from an unsecured microfinance-heavy portfolio to a more balanced and secured asset mix, with secured loans making up 47% of the book as of December 2024. While the microfinance industry in India faced a significant downturn through 2024 due to over-lending and regulatory tightening, Suryoday entered the crisis with a key cushion: nearly 95% of its unsecured loans are covered under the CGFMU guarantee scheme, which caps the bank’s credit loss exposure to a manageable level. Even in a worst-case scenario of 15% credit losses, Suryoday’s net burden is estimated at just ₹210 crore — equivalent to its FY24 net profit.

The bank recently traded at ₹100 per share, implying a market capitalization of $123 million and a deeply discounted valuation of 0.55x book. With a capital adequacy ratio of 26.9% — well above the regulatory minimum — and a resilient funding base built on retail term deposits, Suryoday has the balance sheet strength to weather sector volatility. While gross NPAs spiked to 5.5% in Q3FY25 due to delayed recognition, net NPAs adjusted for expected guarantee recoveries stood at just 0.1%, suggesting the credit drag may be more optical than structural. The bank’s revenue has grown steadily from $90 million in FY21 to $224 million for the trailing nine months of FY25, with improving profitability in recent quarters.

Looking forward, Suryoday is positioned to benefit from both a cyclical rebound in the microfinance space and its own strategic pivot toward secured lending. By March 2027, secured loans are expected to make up 60% of the total book, enabling a more stable earnings profile. If the microfinance sector follows a classic boom-bust-survivor cycle, Suryoday is well-placed to emerge as a consolidator, with increased market share and profitability. On conservative estimates of ₹200 book value and 1.5x P/B, the stock could triple from current levels over the next two years.

Key risks include the possibility of higher-than-expected credit losses in the microfinance portfolio, procedural delays or disputes in CGFMU guarantee payouts, and any signs of deterioration in the secured loan book. However, with its fortified balance sheet, significant regulatory support, and clear path to asset quality normalization, Suryoday represents a classic mispriced recovery play in Indian financials, offering long-term investors a rare combination of downside protection and asymmetric upside.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Amey Kulkarni operates a boutique investment advisory that partners with select individuals and family offices in their journey of wealth creation through investments in the Indian equity markets. Amey worked in the corporate sector for a decade with experience spanning across India, Europe and African markets. Amey has also worked closely with the top management of L&T (Chairman’s office) and the MD&CEO office at Jindal Steel & Power handling responsibilities of corporate strategy and business planning. Having gained unique insights into the internal workings of large diversified businesses from close quarters, Amey now applies the learnings to run an investment fund at Candor Investing. At Candor Investing, Amey invests in companies that don’t require external capital, have the ability to grow for a long time and are run by honest and hungry management. Being passionate about sharing the learnings and insights gained out of his investment experience, Amey occasionally takes up visiting faculty assignments at various Indian business schools. He is also a contributing author to the Moneylife Magazine which is renowned for pointing out corporate governance issues and championing investor awareness campaigns.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

Repco Home Finance: Deep Value Opportunity in Affordable Housing

April 8, 2025 in Asia, Asian Investing Summit 2025, Asian Investing Summit 2025 Featured, Audio, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts

Rajeev Agrawal of DoorDarshi Advisors presented his in-depth investment thesis on Repco Home Finance (India: REPCOHOME) at Asian Investing Summit 2025.

Thesis summary:

Repco Home Finance is a small-cap housing finance company in India, focused primarily on self-employed and salaried customers in the under-penetrated affordable housing market. With a 230-branch network and a customer base concentrated in Tier 2 and Tier 3 cities, Repco offers loans through direct sales, loan camps, and distribution agents. Despite growing assets under management at only 5% CAGR over the past six years, the firm has delivered stronger PAT growth of 10.6% annually. A combination of prudent underwriting, improving asset quality, and a resilient customer base has enabled Repco to generate consistently high returns on equity — averaging 14% over the last decade and 13% through COVID-disrupted years.

The company recently traded at ₹335 per share, or approximately $244 million in market cap, representing just 4.9x trailing earnings and 0.7x book value. With a capital adequacy ratio of 32.5%, Tier 1 capital at 31.7%, and improving credit metrics, the balance sheet is robust. Non-performing assets have steadily declined, and loans disbursed post-COVID are showing stronger repayment behavior, leading to lower credit costs. Net interest margins and spreads have improved steadily, driving both income and profitability in recent quarters. While management transition remains a key overhang, incoming CEO T. Karunakaran — an internal veteran who served previously as CFO and COO — is expected to provide continuity and operational clarity, with strategic direction to emerge in coming quarters.

Repco’s performance still lags behind larger Indian housing finance peers in terms of scale and growth, but the valuation gap has widened disproportionately. Peers trade at median multiples of 2.1x book and 19x earnings despite delivering similar long-term ROEs and slightly stronger growth. If Repco’s return profile holds and loan book growth accelerates even modestly, a re-rating is plausible. Management has guided for 15–20% PAT growth, and even assuming a conservative 12% CAGR and a re-rating to 8x P/E, the stock could double over the next 2.25 years—implying a 40% annualized return.

The market’s skepticism stems from a legacy of underperformance, uncertain growth prospects, and past leadership that overpromised and underdelivered. However, recent improvements in asset quality, profitability, and capital efficiency suggest a turning point. As liquidity builds and management credibility is re-established, Repco is positioned as a classic deep value play. Investors with patience and a long-term horizon may find a compelling margin of safety at current levels.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Rajeev Agrawal is the Fund Manager and Managing Partner at DoorDarshi India Fund. DoorDarshi India Fund is a US-based fund that focuses on investing in Indian equities. Rajeev is also the founder of DoorDarshi Advisors, a General Partner to DoorDarshi India Fund. Rajeev has been investing in the US and Indian equity markets for 15+ years. Rajeev follows Value Investing principles and finds that the Indian equity market provides wonderful opportunities for his style of investing. Prior to starting DoorDarshi, Rajeev was a Technology executive focusing on the Financial Industry and has worked with IHS Markit, Goldman Sachs, Bank of America, JP Morgan and Dresdner Bank. Rajeev did his B.Tech from IIT Bombay and MBA from IIM Calcutta.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

MAS Financial: Non-Banking Financial Company With Strong Track Record

April 8, 2025 in Asia, Asian Investing Summit 2025, Asian Investing Summit 2025 Featured, Audio, Diary, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts

Gokul Raj Ponnuraj of Bavaria Industries Group presented his investment thesis on MAS Financial Services (India: MASFIN) at Asian Investing Summit 2025.

Thesis summary:

MAS Financial is an Indian NBFC (non-banking financial) with a terrific track record of compounding book value per share, lending AUM, earnings per share etc at 25%+ for the last two decades. The owner-operator has consistently focused on steady growth with minimal equity dilution and that has allowed him to continue to own >65% of the firm. The firm has a long term culture with low employee turnover and conservative lending policies (‘extend credit only where it is due’ is their core philosophy).

The firm has a highly granular retail loan portfolio that is diversified across 4 lending segments. The firm has consistently delivered post-tax ROA’s of 3%+. Even during the COVID wave 1 and 2, the firm generated 2.8% and 2.7% ROA respectively. With conservative leverage, the firm can deliver 13-14% ROE even in a weak year. On a normalized basis, the firm can sustainably deliver 2.8-3.2% ROA and 16-18% ROE with little volatility. Management expects to grow their AUM at 20-25% CAGR for the next several years.

The stock since its IPO has traded at a meaningful premium to the NBFC basket at >3X price to book value. During the ongoing SMID correction in Indian markets, the stock has started to trade at an attractive valuation of 1.6X price to book value and 14X price to earnings. This is attractive for a business with a well capitalized balance sheet (Debt/ Equity of 3.5X) and scalable operating model in a high growth industry. Gokul Raj believes the recent price provides an attractive entry point into a long term compounder.

Disclaimer: We have accumulated around 1.5% of the firm over the last few months and hence biased in our analysis. Please do your own research and we would be happy to hear any contrarian opinion to our analysis.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Gokul Raj Ponnuraj is a value investor with a focus on small and mid-cap compounders and spin-off’s with a bias towards emerging markets. He has been investing in the Indian markets since 2006 and in global markets since 2017. Gokul Raj manages the public equities portfolio at Bavaria Industries Group. The firm uses its balance sheet assets (permanent capital) to invest in opportunities with an attractive risk-reward trade off. Gokul Raj holds a Master in Finance degree from London Business School and a CFA charterholder.

Mahindra Holidays: New Leadership to Drive Long-Term Growth Story

April 8, 2025 in Asia, Asian Investing Summit 2025, Asian Investing Summit 2025 Featured, Audio, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts

Nandan Madhiwalla of Punctilious One presented his thesis on Mahindra Holidays and Resorts India (India: MHRIL) at Asian Investing Summit 2025.

Thesis summary:

Mahindra Holidays & Resorts operates under the Club Mahindra brand and offers vacation ownership memberships that grant customers access to a growing network of resorts across India and parts of Europe. At the heart of the business is an upfront membership model that generates float-like capital to fund resort expansion, with revenue recognized slowly over the life of the membership. Though the company’s European subsidiary, Holiday Club Resorts (HCRO) in Finland, has underperformed — particularly post-COVID and due to the Russia-Ukraine conflict — its core India operations have seen a steady improvement in customer satisfaction, occupancy, and cash flows.

In recent weeks, shares of MHRIL traded around ₹325, giving the company a market capitalization of ₹6,600 crore (approximately $765 million). This values the business at less than 1x estimated replacement cost, and the company generates a 5% cash flow from operations yield despite the drag from HCRO. A management transition at both the Mahindra Group and MHRIL itself over the last few years has sharpened operational focus. In particular, the new leadership, in place since May 2024, is expected to accelerate a shift from a historically aggressive “push” model of member acquisition to a more sustainable “pull” strategy backed by better infrastructure and higher customer satisfaction.

The Club Mahindra business is inherently capital-efficient, as the upfront membership fees finance resort development, which in turn enables more memberships to be sold. The company has guided for room inventory to grow from 6,000 by FY25 to 10,000 by 2030, unlocking the potential to add over 200,000 new members. Meanwhile, expiring legacy memberships free up further inventory without additional capex. The deferred revenue pool — essentially revenue visibility over the next several years — continues to build, providing embedded earnings momentum and cash flow stability.

While risks remain, including ongoing losses at HCRO and shifting consumer vacation preferences, MHRIL is clearly transitioning from a legacy of operational inefficiencies to a more disciplined, customer-centric growth story. With improving fundamentals, substantial embedded value in deferred revenue, and a market valuation below the cost to replicate its assets, MHRIL presents a compelling case for long-term investors willing to look past near-term headline noise.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Nandan Madhiwalla is a co-founder and managing partner of East72 Capital Management and Advisors. East72 Capital is a long only India focused fund.

Previously, Nandan has founded and served as the Principal Officer of a SEBI Registered Investment Advisory firm from August 2018 to March 2024, providing equity research-based investment advisory services. Nandan has also held the position of Research Analyst at PPFAS Mutual Fund from May 2015 to February 2018, where he focused on Indian and US stocks in the financial and media sectors. Additionally, he contributed to investment models and reports at Lebenthal Asset Management (Sep 2014 – Mar 2015) and conducted buyside equity research at The Roosevelt Investment Group, Inc (Feb 2012 – Jan 2014). Early in his career, he worked as a Junior Underwriter at FGI Finance, conducting due diligence for asset-based loans.

Nandan holds a CFA Charter (2016) and a Master of Science in Financial & Risk Engineering from New York University (2011). He also earned a bachelor’s in computer science engineering from D J Sanghvi College of Engineering, Mumbai (2008).

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

Major Cineplex: Cinema Leader, Owner-Operated Share Cannibal

April 8, 2025 in Asia, Asian Investing Summit 2025, Asian Investing Summit 2025 Featured, Audio, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts

Michael Fritzell of Asian Century Stocks presented his in-depth investment thesis on Major Cineplex (Thailand: MAJOR) at Asian Investing Summit 2025.

Thesis summary:

Major Cineplex is the dominant cinema operator in Thailand with a commanding 70% market share and a recognizable stable of brands, including EGV and Paragon Cineplex. Run by founder and 30% shareholder Vicha Poolvaraluk, the company offers a diversified revenue base across ticket sales, concessions, advertising, and ancillary entertainment. While severely impacted by COVID-19, Hollywood strikes, and streaming competition, MAJOR appears to be on the verge of a multi-year earnings recovery, aided by a strong 2025–2026 film slate and strategic expansion.

Management has outlined a bullish outlook, forecasting a rebound in attendance to pre-pandemic levels of 44 million by 2027 and announcing plans to open 35–40 new screens in 2025. These new screens are expected to generate ROICs around 15%. Meanwhile, Thailand remains severely under-screened, with only one screen per 58,000 people compared to one per 7,500 in the U.S., highlighting long-term growth potential. The 2025 Hollywood pipeline, alongside a robust Thai movie lineup, marks a sharp contrast to the content drought of prior years and positions the company for meaningful revenue and margin recovery.

MAJOR recently traded at 11.6x forward P/E and 1.0x EV/sales, a steep discount to regional peers such as PVR Inox (India) and Wanda Film (China), despite a cleaner balance sheet and superior market share. Prior to COVID-19, the stock averaged a 19x P/E and delivered consistent operating margins in the 10–14% range. Though current gross profits remain 30% below peak, normalized box office trends and higher ticket prices should close the gap. Share buybacks have also accelerated, with the share count shrinking by roughly 15% in the past year alone.

Risks include shorter theatrical windows and streaming competition, as well as related-party transactions tied to Studio M, a Thai film company controlled by Poolvaraluk. Still, with a base case anchored in industry normalization, stronger content, and capital returns, MAJOR presents a compelling small-cap opportunity in Southeast Asia’s under-penetrated cinema market. Investors could see significant upside if attendance rebounds and the company re-rates even modestly toward historical valuation levels.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Michael Fritzell is a Singapore-based analyst and the author of Asian Century Stocks. He has worked as an analyst and co-portfolio manager in Asia for well over a decade.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

Jupiter Wagons: Well-Run, Owner-Operated Rail Freight Car Leader

April 8, 2025 in Asia, Asian Investing Summit 2025, Asian Investing Summit 2025 Featured, Audio, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts

Rahul Saraogi of Atyant Capital Advisors presented his investment thesis on Jupiter Wagons Limited (India: JWL) at Asian Investing Summit 2025.

Thesis summary:

Jupiter Wagons is India’s largest rail freight car manufacturer, operating in an oligopolistic market with significant barriers to entry due to RDSO certification requirements. The company is a key beneficiary of India’s accelerating shift from road to rail freight, supported by long-term policy tailwinds and electrification advantages. Beyond railcars, JWL has expanded into brakes, truck bodies, containers, EVs, and is now rapidly growing its railway wheels business. This diversification, paired with strong execution and robust demand, positions the company for sustained multi-decade growth.

The case for JWL is framed around both business quality and macroeconomic relevance. With road freight still accounting for 70% of India’s cargo transport and relying heavily on imported oil, rail offers a more sustainable, cost-efficient, and domestically powered alternative. Freight growth is closely tied to GDP, and JWL stands to gain as the broader economy expands and global supply chains continue to realign toward India. Despite being in a sector often overlooked by global investors, Jupiter Wagons enjoys pricing power, strong demand visibility, and the opportunity to consolidate market leadership in a highly regulated industry.

JWL is led by Vivek and Vikash Lohia, second-generation entrepreneurs with Western educations and a focus on governance and capital stewardship. The business is low in working capital intensity, generates ample free cash flow, and maintains low leverage. Capital allocation has been consistently prudent, driving both margin expansion and high returns on capital. The company reported a 28% RoE, $63 million in net profit on $640 million in revenue, and recently traded at 29x earnings — valuation levels that are justified given its dominant positioning and long growth runway.

While the broader Indian market has experienced volatility since mid-2024, Rahul sees this as an opportune moment to initiate or add to positions in structurally advantaged businesses like Jupiter Wagons. The secular growth thesis remains intact, and the current pullback offers an attractive entry point into a capital-efficient industry leader with years of expansion ahead. As rail continues to gain modal share and JWL leverages its scale and execution, the company is likely to command a premium multiple over time.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Rahul Saraogi is the founder and managing director of Atyant Capital Advisors, advisor to the Atyant Capital family of funds. In the last two decades he has focused on the Indian markets. His mission is to consistently identify the best 10-15 investment ideas from among the thousands of publicly- traded Indian corporations. Rahul’s value-based investment philosophy stands apart due to his belief in the paramount importance of corporate governance, specifically how management operates with its minority shareholders in mind. Rahul is the author of “”Investing in India: A Value Investor’s Guide to the Biggest Untapped Opportunity in the World””, a definitive guide on navigating the Indian markets published by John Wiley & Sons.

Rahul graduated from the Wharton School of the University of Pennsylvania with a degree in Economics. Outside of Atyant, he practices Vipassana, a 2,500 year-old meditation technique that helps people see things as they really are. Rahul splits time between Chennai and New York.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

Piramal Pharma: Capacity Expansion Supports Strong Growth Prospects

April 8, 2025 in Asia, Asian Investing Summit 2025, Asian Investing Summit 2025 Featured, Audio, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts

Naveen Chandramohan of Itus Capital presented his in-depth investment thesis on Piramal Pharma (India: PPLPHARMA) at Asian Investing Summit 2025.

Thesis summary:

Piramal Pharma is strategically positioned for long-term growth, leveraging its strong foothold in the Contract Development and Manufacturing Organization (CDMO) space, particularly in Antibody-Drug Conjugates (ADCs), which is expected to see a significant market expansion.

The company has invested in capacity expansion, including a 70% increase at its Grangemouth facility, and is expanding its sterile injectables facility in Kentucky, strengthening its ability to serve the growing global demand.

With a dominant position in Sevoflurane in the U.S. and plans for geographic expansion, Piramal Pharma also aims to scale its high-margin Indian Consumer Healthcare business.

The potential to generate robust EBITDA growth — forecasted to reach ₹2200 crore by FY27 and ₹3800 crore by FY30 — along with a focus on reducing debt, positions Piramal Pharma as an attractive investment opportunity, despite risks associated with regulatory pressures and high product concentration.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Naveen Chandramohan, the Founder and Fund Manager of ITUS Capital, believes in having a shared commitment to growth, an ideology that sets him and ITUS apart from other players in the industry. As one of the finest portfolio managers in India, he believes that asset management firms should take a fiduciary responsibility in working for investors and aligning the fee structure for the clients. Itus is owned by the employees of the firm, with an ownership mindset of building the business. Today, Itus manages USD 220mm with offices across Chennai, Bangalore and Houston. Itus has been set up with an institutional team with 22 members across the 3 locations. The Investment Committee come with deep expertise of managing money across public and private markets and have an average experience of 25 years each between them,

Naveen began his career with Lehman Brothers in Tokyo, in the equity and warrant markets as a senior analyst and was one of the fastest graduates to be promoted to a Vice president of Lehman when he moved to Hongkong in 2008. Post going through the bankruptcy with Lehman, Naveen got the opportunity to set up the Asia ex-Japan business for Nomura. Naveen grew the business to a USD 2bn book with a PL of USD 120 mm in 2 years.

In 2010, Naveen moved out of Nomura to join Oracle Capital, an Asia focused fund as a fund manager, managing a USD 200mm India focused fund for them. Naveen managed money for 5.5 years at Oracle and was awarded the best fund manager for 3 years in a row (2012-14). He then joined Hutchin Hill as a fund manager and Responsible Officer to set up their Hong Kong office where he ran a USD 450mm India focused fund. Naveen returned to India in 2017 to set up Itus Capital.

At Itus, Naveen manages a single-strategy multi-cap fund having compounded returns of 22.3% (net of fees and expenses). The hall mark of the returns has been the consistency of the performance where the rolling returns over any 3-year period has consistently beaten the benchmark.

Itus Capital was set up as a vehicle to manage the partners net worth first with a vision of complete skin in the game. Itus has scaled into one of the best multi-cap funds in the country with a track record of close to 7.5 years since inception. At Itus, Naveen runs a growth-oriented fund with a focus on investing in businesses across sectors but with an emphasis on cash flows.

He did his engineering from BITS Pilani in Electrical engineering and his MBA from IIM Bangalore. He graduated from BITS Pilani as a gold medalist and from IIM Bangalore in the Deans Merit List (Top 10 in the batch).

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

Why Every Investor Must Understand Capital Cycle Theory

March 21, 2025 in Audio, Equities, Featured, John's Blog, Latticework, Podcast, Reading Recommendations, The Manual of Ideas

This episode is part of our “Wisdom in Books” series and podcast. Every week we inspire your reading with an exclusive author interview or John’s takeaways from an influential book on investing, business, or life.

This episode is entitled, “Lessons from ‘Capital Returns’, the Classic by Marathon”.

I am delighted to share this new recording with you, as Capital Returns has been hugely influential in shaping my investment philosophy. The book is truly a “must read” for every investor aspiring to long-term greatness.

In this Part One of our two-part series, I take you on a journey through capital cycle theory, as masterfully articulated by Edward Chancellor and London-based Marathon Asset Management.

In Part Two, we will apply capital cycle theory to today’s market environment, seeking to identify exceptional opportunities in capital-starved industries.

Experienced investors know that markets are more than just numbers on a screen — they are living cycles of boom and bust. Capital Returns: Investing Through the Capital Cycle, edited by renowned financial historian Edward Chancellor, shines a spotlight on one of the most fundamental yet underappreciated forces behind those cycles.

The book compiles a decade’s worth of investment essays from Marathon Asset Management, a London-based value firm, offering an insider’s look at how capital flows within industries can make or break investment returns. Far from a typical market chronicle, Capital Returns provides a rigorous framework for investors seeking an edge in understanding market dynamics. Its significance lies in distilling how the ebb and flow of capital — into steel mills, oil wells, tech startups, you name it — ultimately governs competition, profitability, and long-term value creation.

For portfolio managers and value aficionados, the capital cycle framework isn’t just theory; it’s a practical lens for spotting opportunities and risks that traditional analysis might overlook.

At the heart of the book (and our podcast discussion) is the capital cycle concept. Put simply, the capital cycle theory observes that high returns attract excessive capital, which eventually drives returns down, while poor returns repel capital, sowing the seeds of a future recovery. In other words, when an industry is enjoying fat profits and rosy growth projections, companies and investors tend to flood it with money — new entrants, expanded capacity, ambitious projects — until competition and overcapacity inevitably erode those profits. Conversely, when an industry is in the doldrums with abysmal returns, capital investment dries up: weaker players exit, projects get canceled, and supply shrinks, paving the way for the survivors’ fortunes to improve.

This supply-driven feedback loop leads to a powerful mean reversion in economic outcomes. Excess success plants the seeds of its own demise, just as hardship plants the seeds of resurgence. It’s a sophisticated twist on classic boom-bust wisdom, rooted in supply-side economics for investors. Chancellor quips that many analysts fixate on demand trends while ignoring supply, “which is what drives the capital cycle.” By refocusing on metrics like industry capacity, capital expenditure, and competition, investors can anticipate inflection points that others miss. Think of Joseph Schumpeter’s “creative destruction,” but with a balance sheet twist — capital rushing in where it shouldn’t and fleeing where it’s most needed, time and again.

Why should intelligent investors care about this framework? Capital cycle analysis offers a contrarian roadmap to navigate market manias and slumps. Traditional value investing often emphasizes buying cheap and avoiding hype, and the capital cycle provides tangible criteria to do just that. For example, Chancellor notes that following the “trail of investment” can help identify bubbles before they burst. History bears this out: the late-1990s dot-com frenzy and the mid-2000s housing boom were each marked by a surge in capital spending (on telecom networks, new homes, etc.), foreshadowing eventual glut and collapse.

Marathon’s insight was to “avoid sectors where investment is unduly elevated and competition is fierce, and instead seek out areas where capital is scarce and conditions are favorable.” In practice, this meant often being early — venturing into out-of-favor industries that everyone else had given up on — and steering clear of the hot sectors du jour. It’s a strategy requiring patience and independent thinking.

Capital Returns is particularly relevant now, after a long era of cheap money and expansion. As the cost of capital rises again, we’re witnessing the pendulum swing: previously neglected sectors (energy, shipping, basic materials) are becoming attractive as capital expenditure there remains cautious, while some once-booming corners of the market face sobering realities. The book’s lessons serve as a timely reminder that fundamentals eventually matter — exuberance fades, and industries with disciplined investment tend to reward investors in the long run.

In our podcast discussion, we delve deep into these themes, unpacking both the theory and its real-world implications. You’ll hear how Marathon Asset Management applied the capital cycle lens across a range of industries and market regimes, and what they learned over years of trial and error. Key themes include the universality of the capital cycle (from beer breweries consolidating globally, to banks overeagerly expanding credit, to even the rise and fall of cod fishing and wind farms), and how recognizing those patterns can give investors an edge.

We explore why growth vs. value is not a black-and-white distinction — a fast-growing company can still be a great investment if industry supply remains constrained, just as a statistically “cheap” stock can be a trap in an overcapitalized sector.

Another focal point is the role of management: capital cycle investing isn’t just about industries in the abstract, but also about CEOs and boards making savvy (or foolish) capital allocation decisions. Good management can resist the siren song of empire-building and return cash when projects don’t promise adequate returns, whereas bad management may squander advantage by chasing scale at the wrong time.

The episode also touches on how this framework shed light on financial crises — for instance, how surging loan growth and balance-sheet expansion in mid-2000s banking was a red flag well before 2008. We discuss the aftermath of that crisis too, examining the era of “living dead” zombie companies propped up by low rates, and how an investor might distinguish temporary distortions from permanent impairments.

We connect the dots to emerging markets, investigating the paradox of why regions with rapid economic growth (like China in the 2000s) often delivered poor stock returns because endless capital funding kept competition high and returns low.

Below is a breakdown of the major discussion segments in the podcast:

  • Why Capital Returns Matters: Background on the book’s origins and why understanding the capital cycle is crucial for savvy investors. We set the stage by highlighting Chancellor’s involvement and Marathon’s unique perspective, framing the capital cycle as an indispensable tool in a value investor’s toolkit.
  • Defining the Capital Cycle: An explanation of the capital cycle framework. We discuss how capital flowing into booming industries eventually undermines returns, and how capital exiting distressed sectors plants the seeds for recovery. This segment uses simple examples (including Chancellor’s “widget manufacturer” story) to illustrate the boom-bust mechanism from a supply-side angle.
  • Marathon’s Lens and the Supply-Side Focus: Insight into Marathon Asset Management’s contrarian approach. We talk about how Marathon “followed the money” — tracking industry capital expenditures and capacity — to spot bubbles and opportunities. Real historical cues, like 1990s tech capex and 2000s housing construction, are mentioned as evidence of why this lens works when traditional demand-focused analysis falls short.
  • Revisiting Growth vs. Value Through Cycle Dynamics: An exploration of how capital cycle thinking blurs the line between growth and value investing. Here we examine Marathon’s argument that what really matters is industry economics and competitive behavior, not the usual growth/value labels. For example, a high-growth company in a disciplined industry might earn superior returns (and be worth a premium), whereas a “cheap” company in a hot, crowded sector can disappoint.
  • Case Studies Across Industries: A tour through diverse industries to see the capital cycle in action. We highlight stories from the book’s essays – such as the global beer brewery consolidation saga that initially hurt returns before rationalizing, the cyclical swings in commodities and mining, and even niche cases like cod fisheries or wind turbine manufacturing. These cases demonstrate that the capital cycle is a universal phenomenon, cropping up in any sector where investment surges or evaporates.
  • Management Matters — Capital Allocation in Practice: Discussion of the human element in the capital cycle. Using examples like Finland’s Sampo under CEO Björn Wahlroos (a Marathon favorite), we illustrate how astute management can navigate cycles by curbing expansion at the peak and deploying capital at the trough. Conversely, we look at cautionary tales of CEOs who became overconfident empire-builders, only to destroy shareholder value when the cycle turned. This segment reinforces why evaluating management’s capital allocation discipline is a critical part of the investor’s analysis.
  • Financial Sector Cycles and “Accidents Waiting to Happen”: An analysis of how the capital cycle framework applies to banks and financial services. We recount how Marathon’s letters warned of excessive loan growth and leverage in the mid-2000s (especially in European banks) as an “accident waiting to happen.” In this segment, the discussion shows that rapid balance sheet expansion in banking follows the same boom-bust logic: easy credit and aggressive growth precede credit busts and losses. By viewing the 2008 financial crisis through a capital cycle lens, we gain a deeper understanding of how to spot systemic risks early.
  • Post-Crisis Aftermath – The Living Dead: Examination of the unusual post-2008 environment, where massive monetary easing kept many struggling companies alive (the “living dead” or zombie firms). We discuss Marathon’s observations on how ultra-low interest rates and bailouts distorted the natural capital cycle, preventing the usual cleansing of the bust. This part of the conversation tackles the challenge for value investors in distinguishing between temporary market distortions and true value opportunities in the aftermath of a bust.
  • Emerging Markets and the China Syndrome: A deep dive into emerging market growth stories through the capital cycle perspective. Focusing on China as a prime example, we explore the puzzle of high GDP growth paired with poor equity returns. The segment explains how relentless capital investment in booming economies can lead to overcapacity and low returns on equity, underscoring the book’s lesson that economic growth alone doesn’t guarantee investor profits. We also touch on historical parallels in other emerging markets to show this is a recurring theme.
  • Wall Street’s Role at Cycle Extremes: A lighter but insightful look at how market euphoria manifests in corporate finance activity. Drawing on the book’s satirical essay about Wall Street, we discuss signals like flurries of IPOs, frenzied M&A deals, and even the pace of share buybacks as markers of where we might be in the cycle. When investment bankers are busily taking companies public or orchestrating mega-deals, it often coincides with market tops, whereas shareholder-friendly actions like buybacks tend to appear after downturns. Recognizing these patterns can help investors gauge sentiment and avoid being swept up in late-cycle hubris.

In the soon-to-be-published Part Two, we will apply capital cycle theory to today’s market environment. We will highlight sectors (such as energy and shipping) that appear to be on the favorable side of the capital cycle — where years of underinvestment may be setting the stage for strong returns. We will also caution about areas where capital has been pouring in aggressively.

This Part One of our two-part series was recorded on March 13, 2025.

MOI Global